[1]张莉忠,王义围.高血压动脉硬化患者躯体化症状相关因素分析[J].医学信息,2020,33(04):106-108.[doi:10.3969/j.issn.1006-1959.2020.04.032]
　ZHANG Li-zhong,WANG Yi-wei.Analysis on the Related Factors of Somatization Symptoms in Patients with Hypertension Arteriosclerosis[J].Medical Information,2020,33(04):106-108.[doi:10.3969/j.issn.1006-1959.2020.04.032]
点击复制

高血压动脉硬化患者躯体化症状相关因素分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年04期
页码:
106-108
栏目:
临床研究
出版日期:
2020-02-15

文章信息/Info

Title:
Analysis on the Related Factors of Somatization Symptoms in Patients with Hypertension Arteriosclerosis
文章编号:
1006-1959（2020）04-0106-03
作者:
张莉忠; 王义围
（承德医学院附属医院老年病科，河北 承德 067000）
Author(s):
ZHANG Li-zhong; WANG Yi-wei
(Department of Geriatrics,the Affiliated Hospital of Chengde Medical College,Chengde 067000,Hebei,China)
关键词:
高血压; 动脉硬化; 躯体化症状; 臂踝脉搏波传导速度; 踝臂指数
Keywords:
Hypertension; Arteriosclerosis; Somatization symptoms; Brachial-ankle pulse wave velocity; Ankle-brachial index
分类号:
R544.1
DOI:
10.3969/j.issn.1006-1959.2020.04.032
文献标志码:
A
摘要:
目的 探讨高血压动脉硬化患者躯体化症状的情况及相关危险因素。方法 回顾性分析2019年3月~9月我院收治的131例高血压动脉硬化患者临床资料，均进行臂踝脉搏波传导速度（baPWV）和踝臂指数（ABI）检测，并采用躯体化症状自评量表进行评分，根据是否存在躯体化症状分为躯体化症状组（37例）和无躯体化症状组（94例），比较两组临床资料，并分析高血压动脉硬化患者躯体化症状的相关危险因素。结果 两组舒张压、高密度脂蛋白、尿酸、肌酐比较，差异有统计学意义（P＜0.05），而年龄、体质指数、收缩压、空腹血糖、总胆固醇、甘油三酯、低密度脂蛋白、血浆同型半胱氨酸比较，差异无统计学意义（P＞0.05）。Logistic回归分析显示，舒张压、尿酸是高血压动脉硬化患者躯体化症状的影响因素（P＜0.05）。结论 部分高血压动脉硬化患者存在躯体化症状，舒张压、尿酸与高血压动脉硬化躯体化症状的发生相关。
Abstract:
Objective To investigate the somatization symptoms and related risk factors in patients with hypertension arteriosclerosis.Methods 131 patients with hypertension arteriosclerosis admitted in our hospital from March to September 2019,which were tested for brachial-ankle pulse wave velocity (baPWV) and ankle-brachial index (ABI)，and were assessed with somatization symptom checklist. The scores are divided into somatization symptoms group (37 cases) and no somatization symptoms group (94 cases) according to the presence or absence of somatization symptoms.The clinical data between the two groups were compared, and related factors in patients with hypertension arteriosclerosis are analyzed. Results There was a statistically significant difference in diastolic blood pressure, high density lipoprotein, uric acid, and creatinine between the two groups (P<0.05);but there was no significant difference in age, body mass index, fasting blood glucose, total cholesterol, triglyceride, low-density lipoprotein and plasma homocysteine between the two groups (P>0.05).Logistic regression analysis showed that diastolic blood pressure and uric acid were the influencing factors of somatization symptoms in patients with hypertension arteriosclerosis.Conclusion Some patients with hypertension arteriosclerosis have somatization symptoms. Diastolic blood pressure and uric acid are related to the occurrence of somatization symptoms of hypertension arteriosclerosis.

参考文献/References:

[1]中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56. [2]Townsend RR,Wilkinson IB,Schiffrin EL,et al.Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness:A Scientific Statement From the American Heart Association[J].Hypertension,2015,66(3):698-722. [3]Aboyans V,Ricco JB,Bartelink M,et al.2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases,in collaboration with the European Society for Vascular Surgery (ESVS)[J].Rev Esp Cardiol(Engl Ed),2018,71(2):111. [4]中华医学会神经病学分会神经心理学与行为神经病学组.综合医院焦虑、抑郁与躯体化症状诊断治疗的专家共识[J].中华神经科杂志,2016,49(12):908-917. [5]Liu Y,Zhao J,Fan X,et al.Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders[J].Front Psychiatry,2019,10:286. [6]Carney RM,Freedland KE.Depression and coronary heart disease[J].Nat Rev Cardiol,2017,14(3):145-155. [7]Chen Y,Xu B,Sun W,et al.Impact of the Serum Uric Acid Level on Subclinical Atherosclerosis in Middle-aged and Elderly Chinese[J].Journal of Atherosclerosis and Thrombosis,2015,22(8):823-832.

相似文献/References:

[1]颜 明,龚丽娜,王淑清.彩超在高血压患者肾动脉血流动力学检测中的应用分析[J].医学信息,2018,31(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
　YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,31(04):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
　XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(04):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]乔 君,高 翔,王 瑜,等.缬沙坦对原发性高血压患者外周PBMC中IL-17表达的影响[J].医学信息,2018,31(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
　QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,31(04):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育对原发性高血压患者治疗效果的影响[J].医学信息,2018,31(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
　DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,31(04):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]沈 正,王庆海.焦虑抑郁障碍与血压变异性研究[J].医学信息,2018,31(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
　SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,31(04):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[7]左洪亮.苯磺酸左旋氨氯地平片治疗中老年患者 轻中度原发性高血压的疗效观察[J].医学信息,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
　ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,31(04):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[8]袁 敏,周袁成.钙离子拮抗剂类降压药的临床应用与不良反应分析[J].医学信息,2018,31(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
　YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Medical Information,2018,31(04):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
[9]陈学军,李 敏,张 丹,等.社区一体化分级管理模式对社区老年高血压患者的管理效果[J].医学信息,2018,31(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
　CHEN Xue-jun,LI Min,ZHANG Dan,et al.Management Effect of Community Integration Hierarchical Management Mode on Elderly Hypertensive Patients in Community[J].Medical Information,2018,31(04):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
[10]张莉莉.左旋氨氯地平和氨氯地平治疗轻中度高血压临床效果观察[J].医学信息,2018,31(21):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]
　ZHANG Li-li.Clinical Efficacy of Levamlodipine and Amlodipine in Treatment of Mild to Moderate Hypertension[J].Medical Information,2018,31(04):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]
[11]杨光巧,张世益,邓 洁.RDW与高血压、动脉硬化的相关性[J].医学信息,2025,38(01):174.[doi:10.3969/j.issn.1006-1959.2025.01.036]
　YANG Guangqiao,ZHANG Shiyi,DENG Jie.Correlation Between RDW and Hypertension, Arteriosclerosis[J].Medical Information,2025,38(04):174.[doi:10.3969/j.issn.1006-1959.2025.01.036]

更新日期/Last Update: 2020-02-15